Research
Compounded GLP-1 Dispensing Patterns and Vitamin B 12 Coformulation
JAMA ·
The Brief
- A JAMA study uses comprehensive prescription drug monitoring program data to describe compounded weight-loss prescriptions.
- The study examines rates of self-payment and out-of-state dispensing for compounded GLP-1 drugs.
- The study also looks at the ingredients contained in compounded GLP-1s, including vitamin B12 coformulation.
Why it matters
The findings describe how compounded GLP-1 weight-loss drugs are prescribed and dispensed, offering data-based context for regulators, clinicians and researchers following the compounded medication market.
Who’s affected
- clinicians and pharmacists
- health policy researchers and regulators
- #glp-1
- #compounded drugs
- #vitamin b12
- #prescription monitoring
- #weight loss
This study uses comprehensive prescription drug monitoring program data to describe compounded weight-loss prescriptions, rates of self-payment, out-of-state dispensing, and the ingredients contained in compounded GLP-1s.